The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
Subscribe To Our Newsletter & Stay Updated
